SELLAS Life Sciences
SLS
SLS
29 hedge funds and large institutions have $7.79M invested in SELLAS Life Sciences in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% less funds holding
Funds holding: 30 → 29 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
Holders
29
Holding in Top 10
–
Calls
$3.72M
Puts
$27K
Top Buyers
| 1 | +$4.88M | |
| 2 | +$370K | |
| 3 | +$66.4K | |
| 4 |
EH
Equitable Holdings
New York
|
+$35.4K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$27.7K |
Top Sellers
| 1 | -$869K | |
| 2 | -$198K | |
| 3 | -$89.7K | |
| 4 |
Renaissance Technologies
New York
|
-$53K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$25.4K |